» Articles » PMID: 29881212

Length of Stay and Inpatient Mortality Trends in Primary and Revision Total Joint Arthroplasty in the United States, 2000-2014

Overview
Journal J Orthop
Specialty Orthopedics
Date 2018 Jun 9
PMID 29881212
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Retrospective review of the National Inpatient Sample was performed. LOS and IHM were assessed among TJA patients and assessed by comorbidity status. LOS among TJA patients decreased from 4.31 to 5.87 days to 2.83-4.49 days. Relative risk for prolonged LOS among high comorbidity patients ranged from 3.01-5.62. IHM per 1,000 was 5.1 for revision THA, 1.8 for revision TKA, 1.1 for primary THA, and 0.4 for primary TKA. Relative risk for IHM in high comorbidity patients ranged from 443.9-780.9 (p < 0.0001). LOS and IHM decreased significantly across all TJA procedures. LOS and IHM among the highest comorbidity groups are unacceptably high.

Citing Articles

Neighborhood socioeconomic disadvantages associated with prolonged length of stay and non-home discharge following revision total hip and knee joint arthroplasty.

Shimizu M, Chen T, Buddhiraju A, Bacevich B, Huang Z, Kwon Y J Clin Orthop Trauma. 2024; 52:102428.

PMID: 38766389 PMC: 11097079. DOI: 10.1016/j.jcot.2024.102428.


The impact of restricted provision of publicly funded elective hip and knee joints replacement during the COVID-19 pandemic in England.

Penfold C, Blom A, Redaniel M, Jones T, Eyles E, Keen T PLoS One. 2023; 18(11):e0294304.

PMID: 38019830 PMC: 10686417. DOI: 10.1371/journal.pone.0294304.


Mako robotic-arm-assisted total hip and total knee arthroplasty outcomes in an orthopedic oncology setting: A case series.

Hoskins T, Begley B, Giacalone J, De Wilde K, Maguire F, Wittig J J Orthop. 2023; 46:70-77.

PMID: 37942217 PMC: 10630756. DOI: 10.1016/j.jor.2023.10.021.


Preoperative Prediction and Risk Factor Identification of Hospital Length of Stay for Total Joint Arthroplasty Patients Using Machine Learning.

Park J, Zhong X, Miley E, Gray C Arthroplast Today. 2023; 22:101166.

PMID: 37521739 PMC: 10372176. DOI: 10.1016/j.artd.2023.101166.


Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty.

Akamine A, Takahira N, Kuroiwa M, Tomizawa A, Atsuda K Clin Appl Thromb Hemost. 2022; 28:10760296221103868.

PMID: 35642285 PMC: 9163732. DOI: 10.1177/10760296221103868.


References
1.
Memtsoudis S, Gonzalez Della Valle A, Besculides M, Gaber L, Laskin R . Trends in demographics, comorbidity profiles, in-hospital complications and mortality associated with primary knee arthroplasty. J Arthroplasty. 2008; 24(4):518-27. DOI: 10.1016/j.arth.2008.01.307. View

2.
Kurtz S, Ong K, Schmier J, Mowat F, Saleh K, Dybvik E . Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am. 2007; 89 Suppl 3:144-51. DOI: 10.2106/JBJS.G.00587. View

3.
Parvizi J, Sullivan T, Trousdale R, Lewallen D . Thirty-day mortality after total knee arthroplasty. J Bone Joint Surg Am. 2001; 83(8):1157-61. DOI: 10.2106/00004623-200108000-00004. View

4.
Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M . Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am. 2005; 87(7):1487-97. DOI: 10.2106/JBJS.D.02441. View

5.
Kurtz S, Ong K, Lau E, Bozic K . Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am. 2014; 96(8):624-30. DOI: 10.2106/JBJS.M.00285. View